| Item Type | Name |
|
Concept
|
Carcinoma, Hepatocellular
|
|
Academic Article
|
Lower Observed Hepatocellular Carcinoma Incidence in Chronic Hepatitis B Patients Treated With Entecavir: Results of the ENUMERATE Study.
|
|
Academic Article
|
Early detection, curative treatment, and survival rates for hepatocellular carcinoma surveillance in patients with cirrhosis: a meta-analysis.
|
|
Academic Article
|
Simeprevir and Sofosbuvir (SMV-SOF) for 12 Weeks for the Treatment of Chronic Hepatitis C Genotype 1 Infection: A Real World (Transplant) Hepatology Practice Experience.
|
|
Academic Article
|
Preservation of quality of life with doxorubicin drug-eluting bead transarterial chemoembolization for unresectable hepatocellular carcinoma: Longitudinal prospective study.
|
|
Academic Article
|
Mixed Hepatocellular-Cholangiocarcinoma: Is It Time to Rethink Consideration for Liver Transplantation?
|
|
Academic Article
|
Goals and targets for personalized therapy for HCC.
|
|
Academic Article
|
Direct-Acting Antiviral Therapy Not Associated With Recurrence of Hepatocellular Carcinoma in a Multicenter North American Cohort Study.
|
|
Academic Article
|
Liver Allocation Policies in the USA: Past, Present, and the Future.
|
|
Academic Article
|
Provider Attitudes and Practice Patterns for Direct-Acting Antiviral Therapy for Patients With Hepatocellular Carcinoma.
|
|
Academic Article
|
Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection Is Associated With Increased Survival in Patients With a History of Hepatocellular Carcinoma.
|
|
Academic Article
|
Liver transplantation for hepatocellular carcinoma: Management after the transplant.
|
|
Academic Article
|
Lymphoepithelioma-Like Carcinomas: A Rare Variant of Cholangiocarcinoma.
|
|
Academic Article
|
Positron Emission Tomography With Computed Tomography as a Diagnostic and Prognostic Biomarker for Hepatocellular Carcinoma: Ready for Prime Time?
|
|
Academic Article
|
Provider Attitudes Toward Risk-Based Hepatocellular Carcinoma Surveillance in Patients With Cirrhosis in the United States.
|
|
Academic Article
|
Hepatocellular Carcinoma: A Contemporary Approach to Locoregional Therapy.
|
|
Academic Article
|
Locoregional Therapies for Hepatocellular Carcinoma: What Has Changed in the Past Ten Years?
|
|
Academic Article
|
Integrating Genomics Into Clinical Practice in Hepatocellular Carcinoma: The Challenges Ahead.
|
|
Academic Article
|
Hepatocellular Carcinoma: A Contemporary Approach to Locoregional Therapy.
|
|
Academic Article
|
Safety and efficacy of repeat Y90 radioembolization to the same hepatic arterial territory.
|
|
Academic Article
|
Update on the Diagnosis and Treatment of Hepatocellular Carcinoma.
|
|
Academic Article
|
Patient Preferences for Hepatocellular Carcinoma Surveillance Parameters.
|
|
Academic Article
|
Recent Advances in Hepatocellular Carcinoma Treatment.
|
|
Academic Article
|
Systemic Therapy for Hepatocellular Carcinoma.
|
|
Academic Article
|
Treatment-related toxicity and improved outcome from immunotherapy in hepatocellular cancer: Evidence from an FDA pooled analysis of landmark clinical trials with validation from routine practice.
|
|
Academic Article
|
Early Antibiotic Exposure Is Not Detrimental to Therapeutic Effect from Immunotherapy in Hepatocellular Carcinoma.
|
|
Academic Article
|
The Systemic Inflammatory Response Identifies Patients with Adverse Clinical Outcome from Immunotherapy in Hepatocellular Carcinoma.
|
|
Academic Article
|
Editorial: concurrent fatty liver and chronic viral hepatitis: a dual calamity leading to increased risk of hepatocellular carcinoma?
|
|
Academic Article
|
HCC Mortality Trends-In with ALD (and NAFLD) and Out with HCV.
|
|
Academic Article
|
Recent Advances in Systemic Therapies for Advanced Hepatocellular Carcinoma.
|
|
Academic Article
|
Patterns and outcomes of subsequent therapy after immune checkpoint inhibitor discontinuation in HCC.
|
|
Academic Article
|
Integrated use of PD-1 inhibition and transarterial chemoembolization for hepatocellular carcinoma: evaluation of safety and efficacy in a retrospective, propensity score-matched study.
|
|
Academic Article
|
Association between sustained virological response and clinical outcomes in patients with hepatitis C infection and hepatocellular carcinoma.
|
|
Academic Article
|
Progression patterns and therapeutic sequencing following immune checkpoint inhibition for hepatocellular carcinoma: An international observational study.
|
|
Academic Article
|
Phase 1 Randomized Trial of Stereotactic Body Radiation Therapy Followed by Nivolumab plus Ipilimumab or Nivolumab Alone in Advanced/Unresectable Hepatocellular Carcinoma.
|
|
Academic Article
|
Perspective: Advances in liver transplantation for hepatocellular carcinoma - A prototype for transplant oncology.
|
|
Academic Article
|
Combined heart-liver transplantation practices survey in North America: Evaluation and organ listing practices.
|
|
Academic Article
|
Outcomes of beta blocker use in advanced hepatocellular carcinoma treated with immune checkpoint inhibitors.
|
|
Academic Article
|
Recall patterns and risk of primary liver cancer for subcentimeter ultrasound liver observations: a multicenter study.
|
|
Academic Article
|
Effectiveness and safety of atezolizumab-bevacizumab in patients with unresectable hepatocellular carcinoma: a systematic review and meta-analysis.
|
|
Academic Article
|
Segmental Yttrium-90 Radioembolization Using Glass Microspheres Greater than 400 Gray for the Treatment of Intrahepatic Cholangiocarcinoma: A Preliminary Experience.
|
|
Academic Article
|
Contemporary applications of Y90 for the treatment of hepatocellular carcinoma.
|
|
Academic Article
|
Management of Intermediate-Stage Hepatocellular Carcinoma: Systemic Versus Locoregional Therapy.
|
|
Academic Article
|
Characteristics and outcomes of immunotherapy-related liver injury in patients with hepatocellular carcinoma versus other advanced solid tumours.
|
|
Academic Article
|
Baseline neutrophil-lymphocyte ratio and platelet-lymphocyte ratio appear predictive of immune treatment related toxicity in hepatocellular carcinoma.
|
|
Academic Article
|
Combination of transarterial radioembolization with atezolizumab and bevacizumab for intermediate and advanced staged hepatocellular carcinoma: A preliminary report of safety and feasibility.
|
|
Academic Article
|
Tumor Size and Watershed Area Correlate with Incomplete Treatment and Tumor Progression after Selective Radioembolization for Hepatocellular Carcinoma.
|
|
Academic Article
|
Association between bridging therapy and posttransplant outcomes in patients with HCC within Milan criteria: A systematic review and meta-analysis.
|
|
Academic Article
|
Modified Radiation Lobectomy Strategy of Radioembolization for Right-Sided Unresectable Primary Liver Tumors.
|
|
Academic Article
|
Editorial: Role of Yttrium-90 Transarterial Radioembolisation in Advanced Hepatocellular Carcinoma.
|
|
Academic Article
|
Neoadjuvant and adjuvant systemic therapy in HCC: Current status and the future.
|
|
Academic Article
|
ACG Clinical Guideline: Focal Liver Lesions.
|
|
Academic Article
|
Immunotherapy vs Best Supportive Care for Patients With Hepatocellular Cancer With Child-Pugh B Dysfunction.
|
|
Academic Article
|
Prevention, Diagnosis, and Treatment of Hepatocellular Carcinoma.
|
|
Academic Article
|
Targeted therapies in hepatocellular carcinoma: past, present, and future.
|
|
Academic Article
|
The Changing Demographics and Epidemiology of Hepatocellular Carcinoma.
|